ClinicalTrials.govpublic full text
Mutant CALR-peptide Based Vaccine in Patients With Mutated CALR Myeloproliferative Neoplasm
myelofibrosis, essential thrombocythemia, mpn, calr, vaccine, mf, et, peptide, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 832127
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.